Log in to search using one of your social media accounts:


Uganda:New Cancer Machine Starts Work in December
[Observer] The executive director of Uganda Cancer Institute (UCI), Dr Jackson Orem, has assured the public that the new Cobalt 60 radiotherapy machine will be pressed into service by mid-December, raising the hopes of many long-suffering patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2017 Category: African Health Source Type: news

Cordis Comes Back for Another Stent
Cordis is getting back into the coronary stent game. The company, which is now owned by Cardinal Health, landed exclusive rights to sell Medinol's coronary stent portfolio in the U.S. Milpitas, CA-based Cordis is already selling Medinol's NIRxcell cobalt-chromium bare-metal stent and, assuming FDA approves Medinol's EluNIR drug-eluting stent (DES), Cordis will distribute it as well. Medinol is based in Israel. In addition to the Medinol agreement, Cordis recently launched the Tryton Side Branch Stent and two percutaneous transluminal coronary angioplasty (PTCA) balloon catheters. The Medinol agreement, along with the ...
Source: MDDI - October 31, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news

Cordis inks exclusive distribution deal for Medinol ’ s coronary stent portfolio in US
Cordis has inked an exclusive distribution deal to sell Medinol‘s coronary stents in the U.S., the company reported, adding a cobalt-chromium bare-metal stent and a drug-eluting stent to its portfolio. According to the deal, Cordis plans to start selling Medinol’s NIRxcell BMS immediately and will exclusively distribute the company’s EluNir drug-eluting stent if it wins FDA approval. Get the full story at our sister site, Drug Delivery Business News. The post Cordis inks exclusive distribution deal for Medinol’s coronary stent portfolio in US appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Drug-Device Combinations Drug-Eluting Stents Pharmaceuticals Cordis Corp. Medinol Ltd Source Type: news

Cobalt and tungsten -- the key to cheaper, cleaner hydrogen
(Institute of Chemical Research of Catalonia (ICIQ)) Researchers at the Institute of Chemical Research of Catalonia (ICIQ) and Rovira and Virgili University (URV, both in Tarragona, Spain) presented their results in the prestigious scientific journal 'Nature Chemistry'. The new catalyst features cobalt and tungsten, Earth-abundant materials that are way cheaper than current alternatives, based in precious metals like iridium. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 30, 2017 Category: Biology Source Type: news

MOF-derived cobalt nanoparticles catalyze a general synthesis of amines
The development of base metal catalysts for the synthesis of pharmaceutically relevant compounds remains an important goal of chemical research. Here, we report that cobalt nanoparticles encapsulated by a graphitic shell are broadly effective reductive amination catalysts. Their convenient and practical preparation entailed template assembly of cobalt-diamine-dicarboxylic acid metal organic frameworks on carbon and subsequent pyrolysis under inert atmosphere. The resulting stable and reusable catalysts were active for synthesis of primary, secondary, tertiary, and N-methylamines (more than 140 examples). The reaction coupl...
Source: ScienceNOW - October 19, 2017 Category: Science Authors: Jagadeesh, R. V., Murugesan, K., Alshammari, A. S., Neumann, H., Pohl, M.-M., Radnik, J., Beller, M. Tags: Chemistry r-articles Source Type: news

AMRI ’s SSCI Adds Cobalt Light Systems Transmission Raman Spectrometer...
Further enhances solid state characterization and method development capabilities and is uniquely suited for applications requiring acquisition of a large number of spectra for both quantitative or...(PRWeb October 18, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14803856.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2017 Category: Pharmaceuticals Source Type: news

The Dark Side of Electric Cars: Exploitative Labor Practices
The Scottish government recently announced plans to, by 2032, phase out petrol and diesel vehicles. By 2040, the only cars on United Kingdom roads will also be electric, and petrol stations will be replaced by car charging points. Meanwhile, in the United States, Elon Musk has announced the launch of the Tesla Model 3, which he hopes will become the world’s first mass-market electric car. This shift to green technology is extremely welcome. Climate change is one of the biggest human rights challenges of our time, and cities from London to Delhi are choking on vehicle fumes. The move to electric cars will improve air ...
Source: TIME.com: Top Science and Health Stories - September 28, 2017 Category: Consumer Health News Authors: Mark Dummett Tags: Uncategorized technology world affairs Source Type: news

Cobalt nanoparticles for making amines cheaply and simply
New catalyst could compete with those based on precious metals for the industrially important reductive amination reaction. (Source: Nanotechweb.org News)
Source: Nanotechweb.org News - September 25, 2017 Category: Nanotechnology Authors: Belle Dum é Source Type: news

Largest study to date evaluates occupational health risks to hardmetal workers
(University of Pittsburgh Schools of the Health Sciences) Workers in the hardmetal industry are not at increased risk for lung cancer or any of 63 other potential causes of death, concluded the largest and most definitive study on this population to date. The study of more than 32,000 workers in five countries was performed after smaller French and Swedish studies indicated that tungsten carbide with a cobalt binder -- the primary ingredients in hardmetal -- may be linked to an increased risk of lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 30, 2017 Category: Cancer & Oncology Source Type: news

Uganda: New Cancer Machine Not the Best, Says Doctor
[Observer] Dr Ekwaro Obuku, the general secretary of the Uganda Medical Association, says the new Cobalt-60 cancer machine for radiotherapy services, which arrived at Mulago national referral hospital on Wednesday is not the best for cancer patients since it uses old technology, has many side effects and treats fewer patients per day. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 18, 2017 Category: African Health Source Type: news

Uganda: Cancer Machine Arrives, to Start Work in October
[Observer] Cancer patients in need of radiotherapy treatment can breathe a sigh of relief after the long-awaited Cobalt-60 machine finally arrived at Mulago hospital on Wednesday this week. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 18, 2017 Category: African Health Source Type: news

Cobalt in hip replacement parts found to cause Alzheimer's disease via heavy metals poisoning
(Natural News) Hip replacement parts are often made with cobalt, a toxic heavy metal. Doctors are now concerned that cobalt poisoning is causing Alzheimer’s among hip replacement recipients. As reported by the UK Daily Mail: The Medicines and Healthcare products Regulatory Agency announced last month that patients would be called in for x-rays and blood... (Source: NaturalNews.com)
Source: NaturalNews.com - August 16, 2017 Category: Consumer Health News Source Type: news

India institutes price caps for orthopedic knee implants
Indian regulators are capping prices of orthopedic knee implants as the country looks to lower the cost of medical devices. The country’s drug pricing authority said today that orthopedic implants in the country had unjustified, unreasonable and irrationally high trade margins, which led to exorbitant pricing. Minister of Chemicals and Fertilizers Ananth Kumar said the prices had been capped “in public interest” during a new briefing today. With the change, Kumar said that commonly used cobalt chromium knee implants, previously priced up to $3,895 (INR ₹250,000), would be capped at $852 (INR ₹54,720)....
Source: Mass Device - August 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Healthcare Reform Orthopedics Regulatory/Compliance Abbott India Medtronic Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Abbott’s new contact ablation catheter: Here’s what you need to know The new TactiCath contact ablation catheter unites EndoSense and St. Jude Medical technologies that Abbott acquired, marrying fiber optics, flexib...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic launches DAPT study for Resolute Onyx DES
Medtronic (NYSE:MDT) said today that it’s launching a study of dual anti-platelet therapy and its Resolute Onyx drug-eluting stent. The 2,000-patient study is designed to compare a one-month course of aspirin and an anti-coagulant in conjunction with the Resolute Onyx device or the BioFreedom DES made by Biosensors International (PINK:BSNRY). The Resolute Onyx stent is made from a single strand of cobalt alloy, formed into a sinusoidal wave with a radio-opaque core, Medtronic said. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic launches DAPT study for Resolute Onyx DES app...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Drug-Device Combinations Stents Medtronic Source Type: news

How hospital equipment allows terrorists to easily make dirty bombs that could irradiate entire cities
(Natural News) When ISIS took control of the northern Iraqi city of Mosul in 2014, it apparently had the makings of a devastating dirty bomb at its fingertips. Cobalt-60 is a common element in medical radiotherapy equipment used in cancer treatment. For about three years after ISIS overran the city, wary U.S. intelligence agencies were aware... (Source: NaturalNews.com)
Source: NaturalNews.com - August 7, 2017 Category: Consumer Health News Source Type: news

Avalign Technologies acquires Thortex and Millennium Surgical
Avalign Technologies announced that is has acquired Thortex and Millennium Surgical. The financial details of the deal were not disclosed. Thortex provides precision manufacturing, porous coatings and metal injection solutions to the medical device market. It has porous coating solutions for titanium and cobalt-chrome orthopedic implants and manufacturing and engineering technologies for medical device OEMs. Millennium Surgical offers specialty surgical instruments and more than 17,000 branded SKUs in a variety of clinical areas like neurosurgery, ophthalmics and orthopedics. Get the full story on our sister site, Medical ...
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Mergers & Acquisitions Avalign Technologies Millennium Surgical Thortex Source Type: news

Toxic metal hip replacements could cause Alzheimer's
Dr Neil McGuire, clinical director of medical devices at the MHRA, said he wanted to establish whether cobalt leached from the implants was causing adverse effects. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2017 Category: Consumer Health News Source Type: news

Fresh warning over toxic metal hip replacements
Dr Neil McGuire, clinical director of medical devices at the MHRA, said he wanted to establish whether cobalt leached from the implants was causing adverse effects. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2017 Category: Consumer Health News Source Type: news

Agilent Tech pays $52m for Raman spectroscopy dev Cobalt
Agilent Technologies said today it acquired UK-based Raman spectroscopic instrument dev Cobalt Light Systems for $51.5 million (GBP £40 million). Cobalt develops benchtop and handheld Raman spectroscopic instruments based on proprietary technologies to enable through-barrier identification of chemicals and materials, the company said. Read the whole story on our Sister Site, Medical Design & Outsourcing The post Agilent Tech pays $52m for Raman spectroscopy dev Cobalt appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Agilent Technologies Inc. Source Type: news

FDA clears Biotronik ’ s Pro-Kinetic Energy cobalt chromium stent
Biotronik said today it won FDA approval for its Pro-Kinetic Energy cobalt chromium coronary stent system, with indication for use in patients with arterial blockages between 2.25 and 4mm in diameter and lesion length up to 31 mm. The Pro-Kinetic Energy stent system is designed to imProve coronary luminal diameter in patients with new or recurring blockages in the coronary arteries. The Berlin, Germany-based company said FDA apProval of the device based off of results from its Biohelix-I clinical study. “We’re proud to make the Pro-Kinetic Energy stent available to physicians and their patients in the US. ...
Source: Mass Device - February 15, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Stents Biotronik Source Type: news

Scientific experts agree with NTP about cobalt and cancer
A panel of experts agreed with the National Toxicology Program that a class of cobalt and cobalt compounds is reasonably anticipated to be a human carcinogen. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - August 7, 2015 Category: Environmental Health Source Type: news

Review: cobalt toxicity and artificial metal hips
4.5 out of 5 stars Systemic toxicity related to metal hip prostheses. Bradberry SM et al. Clin Toxicol 2014;52:837-847. Abstract As TPR has reported before, cobalt poisoning can cause hypothyroidism, cardiomyopathy, and neurotoxicity. Neurological manifestations include: optic nerve damage and retinopathy with reduced visual acuity bilateral nerve deafness and tinnitus polyneuropathy (sensory and motor) cognitive impairment and memory loss A number of papers and case reports have described clinical cobalt toxicity related to metal-on-metal hip prostheses or revision of a failed ceramic prosthesis with...
Source: The Poison Review - September 25, 2014 Category: Toxicology Authors: Leon Tags: Medical cardiomyopathy cobalt toxicity hip replacement hypothyroidism neurotoxicity prosthesis Source Type: news

You don’t need Dr. House to suspect cobalt toxicity in a patient with an artificial hip
Dr. Gregory House 3 out of 5 stars Cobalt intoxication diagnosed with the help of Dr. House. Dahms K et al.  Lancet 2014 Feb 8;383:574. Full text This is a neat short case report that can fix in the mind the features of cobalt toxicity. A 55-year-old man came to clinic with a history of: severe heart failure (ejection fraction = 25%) decreased hearing acuity decreased visual acuity fever of unknown origin hypothyroidism abdominal discomfort lymphadenopathy All signs and symptoms seemed to have developed over the year before presentation. Further history revealed that the patient had undergone bilateral hip replaceme...
Source: The Poison Review - February 12, 2014 Category: Toxicology Authors: Leon Tags: Medical artificial hip prosthesis cobalt toxicity dr. gregory house Source Type: news

Cobalt replacements make solar cells more sustainable
(University of Basel) Researchers at the University of Basel have successfully replaced the rare element iodine in copper-based dye-sensitized solar cells by the more abundant element cobalt, taking a step forward in the development of environmentally friendly energy production. The journal Chemical Communications has published the results of these so-called Cu-Co cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 2, 2013 Category: Biology Source Type: news

Hubble telescope discovers alien 'deep blue' planet
The ageing space telescope has been used to identify the true colour of a planet beyond our solar system for the first timeThe heavens are home to an alien world that shines a deep cobalt blue in a solar system far, far away from our own.Astronomers used the ageing Hubble space telescope to determine the true colour of the distant world, the first time such a feat has been achieved for a planet that circles a star other than the sun.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 12, 2013 Category: Science Authors: Ian Sample, science correspondent Tags: Hubble space telescope Science Alien life UK news World news Source Type: news

Cobalt-Chromium Everolimus-Eluting Stents Best in STEMICobalt-Chromium Everolimus-Eluting Stents Best in STEMI
Cobalt-chromium everolimus-eluting stents are the best stents for patients with ST-segment elevation myocardial infarction (STEMI), according to a new meta-analysis. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 17, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news